Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

or COPD. Many of those patients purchase inhalers on a monthly basis and rely on them to help them breathe. Democrats have framed the high cost of inhalers as a symptom of America’s broader ...

Table 1 presents our estimates of the direct costs of COPD. Table 2 presents our estimates of the direct costs of asthma. Table 3 presents estimates of the indirect costs of COPD and asthma.

In the USA, 14.8 million people were diagnosed with chronic obstructive pulmonary disease (COPD) in 2010 and nearly as many are expected to go undiagnosed. Indirect costs of COPD were projected to ...

Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...